Allogeneic and Autogenous Bone Grafts Are Affected by Historical Donor Environmental Exposure

Abstract

Background Bone graft materials are routinely evaluated for infectious agents; however, data regarding contamination of bone graft from environmental exposure of the donors to osteotoxic substances such as lead are not routinely available. In animal models, stored lead in bone has been shown to impair fracture healing and osteocyte function. In clinical studies, lead is linked to skeletal disease at relatively low concentrations. Presumably the levels of lead in allografts mirror the level of lead in bone in the population; however, the degree to which processing might decrease this and the frequency with which potentially osteotoxic levels appear in bone grafts have not been studied. Questions/purposes (1) Does processing of donor bone for allografts result in lower concentrations of lead in commercial allograft when compared with autologous bone graft; and (2) what proportion of bone grafts contain potentially osteotoxic levels of lead from[2.0 to 20.0 lg/g corresponding to environmental exposure? Methods Allograft from commercial sources and autologous bone graft materials were examined for lead content using ICP-atomic absorption spectrophotometric analysis. We analyzed bone graft specimens from 42 donors, including 26 corticocancellous tibial specimens from commercially available bone graft materials and 16 autograft corticocancellous tibial specimens. Lead levels were determined for the cortical (n = 42) and cancellous (n = 42) portions of each specimen. For quality control, all instru-

BMSC-Exosomes Carry Mutant HIF-1α for Improving Angiogenesis and Osteogenesis in Critical-Sized Calvarial Defects

“…Autologous bone grafting is often considered the gold standard for repairing bone defects, but its use has a number of limitations, including a high incidence of donor sites, limited availability, relatively high and unpredictable autologous absorption (Benic and Hämmerle, 2014). Homozygous allogeneic bone grafting limits its potential clinical application due to high susceptibility to immune rejection (Behrend et al, 2016). With the development of bone tissue engineering, the development of scaffold materials has made great progress, beta-tricalcium phosphate (β-TCP) has good bioactivity, biodegradability, biocompatibility and is an ideal material for bone tissue repair and replacement (Gao et al, 2014;Oryan and Alidadi, 2018), but it doesn't exactly mimic the physiological function of bone tissue.…”

Novel standardized massive bone defect model in rats employing an internal eight‐hole stainless steel plate for bone tissue engineering

“…Autogenous bone grafts promote an obvious repair effect but have the shortcomings of limited bone mass, complex surgery, and a high risk of complications (Moura et al, ). Allograft bone, bone xenograft, and artificial bone grafts each have their own limitations, including immunogenicity and risk of infection (Behrend et al, ). In recent years, an increasing number of studies have focused on substitute bone tissue materials in animal models of bone defects.…”

Functionalization of Synthetic Bone Substitutes

“…Though, donor site morbidity and finite resources limit the applicability of autologous bone tissue [ 3 ]. The application of allogenic bone materials is restricted to high rates of hard and soft-tissue infections and contamination with osteotoxic substances [ 4 , 5 ]. Therefore, major efforts have been made to create alternatives for treatment of bone defects.…”